OLANDER CLINICAL CONSULTING 1 ApS: Financial statements 2022
CVR: 35532900
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
OLANDER CLINICAL CONSULTING 1 ApS (CVR 35532900) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,257 and a net result of DKK 29,664 compared with DKK 28,680 the year before. Equity in the 2022 report amounted to DKK 113,946. The solvency ratio was 96.1%.
- Gross Profit
- DKK -7,257
- Profit/Loss
- DKK 29,664
- Equity
- DKK 113,946
- Total Assets
- DKK 118,588
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -7K | 30K | 114K | - |
| 2021 | - | -7K | 29K | 109K | - |
| 2020 | - | -6K | 23K | 104K | - |
| 2019 | - | -6K | 22K | 108K | - |
| 2018 | - | -8K | 27K | 116K | - |
Official annual report
Keep an eye on OLANDER CLINICAL CONSULTING 1 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
OLANDER CLINICAL CONSULTING 1 ApS has published its annual report for 2021. Gross profit came to DKK -6,657, and the net result was DKK 28,680.
About OLANDER CLINICAL CONSULTING 1 ApS
OLANDER CLINICAL CONSULTING 1 ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK 38,365 and a net result of DKK 28,455 compared with DKK 30,979 the year before. Equity in the 2025 report amounted to DKK 167,137.
